Artwork

Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Homestemix Inc. | Jushi Holdings Inc.

0:52
 
Share
 

Manage episode 418140086 series 180440
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company’s Phase II randomized clinical trial results today. The publication highlights the results of no option critical limb ischemia patients who started the clinical trial with an ulcer, comparing wound healing, amputation, and mortality between the patients treated with ACP-01 and patients treated with a placebo.
Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, applauded Governor Shapiro’s continued advocacy for a comprehensive policy for cannabis, including legal adult-use sales. Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi, commented, "The message is clear that the public wants a legal, regulated adult-use cannabis marketplace."
For more information, please visit StockDayMedia.com
  continue reading

1470 episodes

Artwork

Homestemix Inc. | Jushi Holdings Inc.

Stock Day Media

61 subscribers

published

iconShare
 
Manage episode 418140086 series 180440
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company’s Phase II randomized clinical trial results today. The publication highlights the results of no option critical limb ischemia patients who started the clinical trial with an ulcer, comparing wound healing, amputation, and mortality between the patients treated with ACP-01 and patients treated with a placebo.
Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, applauded Governor Shapiro’s continued advocacy for a comprehensive policy for cannabis, including legal adult-use sales. Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi, commented, "The message is clear that the public wants a legal, regulated adult-use cannabis marketplace."
For more information, please visit StockDayMedia.com
  continue reading

1470 episodes

Kaikki jaksot

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide